Van Gieson E J, Skalak T C
Department of Biomedical Engineering, University of Virginia Health Sciences Center, Charlottesville 22908, USA.
Microcirculation. 2001 Feb;8(1):25-31.
The process of microvessel growth and remodeling depends on the presence of matrix metalloproteinases (MMPs) in a specific spatial pattern of expression. This study characterizes the spatial distribution of metalloproteinase-9 (MMP-9) expression during microvascular remodeling in the rat spinotrapezius muscle.
Female Sprague-Dawley rats (4 weeks old) were administered the alpha1-adrenergic blocker prazosin for 7 days to induce chronic vasodilation and associated increases in capillary and arteriolar density. MMP-9 expression was analyzed by Western blotting analysis of microdissected regions of muscle and immunolabeling of muscle sections.
Capillary density expressed as both capillary-to-fiber ratio (C/F) and capillaries per mm2 increased significantly (p < 0.01) due to prazosin administration. Western blotting on microdissected regions of spinotrapezius muscle showed that there was an increase in MMP-9 expression in prazosin-treated animals. Additionally, the Western blots showed a presence of the activated form of MMP-9 in regions of spinotrapezius muscle containing vessels on the order of capillaries and small arterioles. Immunohistochemistry demonstrated that MMP-9 significantly increased in the muscles of treated animals in areas within the vessel walls of microvessels greater than 20 microm in diameter. However, interstitial MMP-9 expression did not significantly increase with prazosin administration.
These results demonstrate that the expression of MMP-9 increases during in vivo microvascular remodeling in adult skeletal muscle. The MMP-9 expression is limited to larger (>20-microm diameter) microvessels, suggesting a role for MMP-9 in the remodeling of such vessels during prazosin-induced vasodilation and the subsequent capillary proliferation.
微血管生长和重塑过程取决于基质金属蛋白酶(MMPs)以特定空间表达模式的存在。本研究描述了大鼠斜方肌微血管重塑过程中金属蛋白酶-9(MMP-9)表达的空间分布。
对4周龄雌性Sprague-Dawley大鼠给予α1-肾上腺素能阻滞剂哌唑嗪7天,以诱导慢性血管舒张及相关的毛细血管和小动脉密度增加。通过对肌肉显微切割区域的蛋白质免疫印迹分析和肌肉切片免疫标记来分析MMP-9的表达。
由于给予哌唑嗪,以毛细血管与肌纤维比率(C/F)和每平方毫米毛细血管数表示的毛细血管密度显著增加(p < 0.01)。对斜方肌显微切割区域的蛋白质免疫印迹显示,哌唑嗪处理的动物中MMP-9表达增加。此外,蛋白质免疫印迹显示在含有毛细血管和小动脉大小血管的斜方肌区域存在活化形式的MMP-9。免疫组织化学表明,在直径大于20微米的微血管血管壁内区域,处理动物的肌肉中MMP-9显著增加。然而,间质MMP-9表达并未因哌唑嗪给药而显著增加。
这些结果表明,在成年骨骼肌体内微血管重塑过程中MMP-9的表达增加。MMP-9的表达仅限于较大(直径>20微米)的微血管,提示MMP-9在哌唑嗪诱导的血管舒张及随后的毛细血管增殖过程中此类血管的重塑中起作用。